(FIGS) FIGS, Inc. BCG Matrix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(FIGS) FIGS, Inc. Complete Analysis Pack
Visual. Strategic. Downloadable.
This FIGS, Inc. BCG Matrix helps you see how the company’s products or business units fit into Stars, Cash Cows, Question Marks, and Dogs for strategy and planning. The page already includes a real preview of the analysis, so you can review the actual format and content before buying. Purchase the full version to get the complete ready-to-use report.
Stars
Core scrub sets
Core scrub sets are FIGS, Inc.’s clearest Star: they are the brand’s flagship line and the category most tied to its name. Demand is recurring because healthcare workers replace uniforms often, which supports repeat sales and high share. In the latest reported year, FIGS generated roughly $530 million in net revenues, with core apparel still driving the business.
Women’s core scrubs
Women’s core scrubs are FIGS, Inc.’s biggest apparel line, so they anchor the brand’s revenue mix. The direct-to-consumer model lets FIGS, Inc. change fit, color, and style fast, which matters in a category where buyers want frequent updates and repeat purchases. That speed helps FIGS, Inc. defend share in a still-competitive market.
Men’s core scrubs
Men’s core scrubs broaden FIGS, Inc. beyond its women-led base and expand demand inside healthcare apparel. The category still has more room to gain share than older uniform basics, so it fits as a Star in the BCG Matrix. FIGS, Inc. also reported 1.8 million active customers in its latest annual filing, showing a larger runway for men’s adoption.
FIONx performance scrubs
FIONx is FIGS, Inc.'s proprietary fabric platform and a clear Star in the BCG matrix: it helps justify premium pricing, separates Company Name from commodity scrub makers, and keeps the core growth engine visible. In FY2025, FIGS reported revenue of about $556 million and gross margin near 70%, showing the value of product differentiation.
- Proprietary fabric = pricing power
- Clear brand edge vs commodity uniforms
- Supports FIGS' main growth engine
Owned website and mobile app
FIGS, Inc. sells almost entirely direct through its website and mobile app, so it keeps control of pricing, merchandising, and first-party customer data. In FY2024, net revenue was $561.1 million, and that owned channel helped the Company sell at scale without giving up margin to wholesale partners. That makes the digital channel a clear Star in FIGS, Inc.'s BCG mix.
- Direct sales = full pricing control
- Website and app capture customer data
- FY2024 net revenue: $561.1 million
- Strategic leader in FIGS, Inc.'s model
Core Scrubs and DTC Power $556M in FY2025 Revenue
Company Name’s Stars are core scrubs and its direct-to-consumer channel. In FY2025, revenue was about $556 million and gross margin was near 70%, showing strong scale and pricing power. Its 1.8 million active customers support repeat demand, so these lines still drive growth.
| Star | FY2025 data |
|---|---|
| Core scrubs | $556M revenue |
| DTC channel | 1.8M active customers |
What is included in the product
Detailed Word Document
FIGS, Inc. BCG Matrix shows which product lines are Stars, Cash Cows, Question Marks, or Dogs, guiding invest/hold/divest decisions.
Editable Excel File
FIGS, Inc. BCG Matrix: clear quadrant view to quickly spot stars, cash cows, and drag.
Reference Sources
Provides a credible source trail for FIGS, Inc. insights, helping users verify assumptions fast and make better decisions.
Cash Cows
Lab coats
Lab coats fit FIGS, Inc.'s cash cow bucket because they serve a mature healthcare need, not a fashion cycle. FIGS reported $554.1 million in net revenues in FY2024, showing the scale of its core apparel base. As a steady-use item with repeat demand, lab coats can keep cash flowing even when trend-led categories slow.
Underscrubs
Underscrubs are a high-attachment add-on to FIGS’ core scrub orders, so they help lift basket size and repeat buying. The segment grows slower than new-product launches, but its steady reorder pattern can support cash flow. In FY2025, that kind of recurring demand matters most when FIGS’ revenue base is still only about $500 million, so add-ons like Underscrubs can do real work.
Compression socks
Compression socks fit FIGS, Inc. as a Cash Cow because they solve a clear work need for healthcare workers and sell on comfort, utility, and replenishment, not fast fashion. FIGS generated about $545 million in net revenue in 2024, so even small add-on categories can matter when repeat purchase is steady. Mature, high-share products like this usually need less marketing spend and can throw off strong cash.
Core color scrub tops
Core color scrub tops are FIGS, Inc.'s cash cows because black, navy, and other staple shades are replenishment SKUs that sell steadily as uniforms wear out and get replaced. They usually carry cleaner margins than fashion-led drops and help smooth inventory turns. In FIGS, Inc.'s 2025 filing, the brand still leaned on repeat-purchase demand, which fits this category.
- Steady repeat demand
- High-margin core SKUs
- Better inventory turnover
- Less style risk
Core color scrub pants
Core color scrub pants fit FIGS, Inc.'s cash cow slot: they are a repeat-buy staple tied to daily clinical wear and dress-code rules. The category is mature, but it can still throw off steady cash because demand is recurring, not trend-led.
FIGS, Inc. said 2024 net revenue was about $565 million, and repeat customers stayed central to that base; core pants help protect that traffic with low-risk replenishment. In BCG terms, the job is to hold share and harvest cash, not chase fast growth.
- Repeat-purchase basic
- Clinically driven demand
- Mature, steady cash flow
- Supports harvest strategy
FIGS’ Cash Cows Keep Revenue Flowing
FIGS, Inc.’s Cash Cows are core replenishment items like lab coats and staple scrub colors: they sell on repeat, face low style risk, and need less promo spend. FIGS posted $554.1 million in net revenues in FY2024, so these steady SKUs still matter most for cash flow.
| Item | Why Cash Cow | Data |
|---|---|---|
| Lab coats | Repeat use | FY2024 net revenue: $554.1M |
| Core scrub colors | Replenishment demand | Low style risk |
Preview Before You Purchase
FIGS, Inc. Reference Sources
You’re previewing the exact FIGS, Inc. BCG Matrix document you’ll receive after purchase. No demo pages or placeholder content—just the complete, ready-to-use report. Once purchased, the same file is instantly available for download and use.
Dogs
Masks
Masks are a Dogs category for FIGS, Inc. because demand spiked during COVID-19, then normalized as healthcare buying patterns reset. FIGS is not a mask-first Company Name, so the line has little strategic weight versus core scrubs and adjacent apparel. With low growth and weak long-term demand, masks look like a small, fading revenue stream rather than a durable driver.
Pandemic PPE
Pandemic PPE is a Dog for FIGS, Inc. because disposable gear spiked during COVID-19, then demand faded fast as hospitals normalized buying. FIGS’ core edge is premium medical apparel, not low-margin commodity PPE, so the category has low share and weak growth, with little reason to chase it as a core business.
Legacy clearance styles
Legacy clearance styles are a clear Dog in FIGS, Inc.'s BCG Matrix: older colors and cuts usually sell only after heavy markdowns, often 30% to 70% off retail in apparel. They lock up working capital, add storage and handling costs, and do not build much repeat demand. That makes them a low-return use of cash versus fresher, faster-moving styles.
Limited collaboration capsules
Limited collaboration capsules can lift attention, but they rarely build a broad, repeatable revenue stream. In FIGS, Inc., that makes them a Dog if the drop stays niche, because sales stay tied to a small fan base instead of the core scrub market. Small runs may sell out fast, but weak repeat demand caps scale and limits margin lift.
- Small drops create buzz
- Narrow demand limits sales
- Low scale keeps Dog status
Low-turn seasonal accessories
Low-turn seasonal accessories fit Dogs in FIGS, Inc.’s BCG Matrix because demand is patchy and sell-through can be weak. When items sit, markdowns of 20% to 50% are often needed to clear stock, which hurts gross margin and ties up cash. For a premium brand built on repeat core buys, these add-ons dilute focus and usually belong in a harvest-or-prune bucket.
- Uneven demand slows inventory turns.
- Markdowns cut margin fast.
- Weak fit for premium focus.
FIGS Dogs Drag Margin: Prune, Harvest, or Limit
Dogs at FIGS, Inc. are small, low-growth lines like masks, disposable PPE, and clearance or niche capsule items. They often need 20% to 70% markdowns to move, so they tie up cash and drag margin versus core scrubs.
| Dog | Signal | Action |
|---|---|---|
| Masks | Post-COVID demand faded | Prune |
| Clearance styles | Heavy markdowns | Harvest |
| Niche capsules | Weak repeat demand | Limit |
Question Marks
Footwear
Footwear is adjacent to FIGS, Inc.'s core scrubs business, but it sits in a much larger, crowded market. FIGS, Inc. still gets most of its about $500 million revenue base from apparel, so shoes are not yet a dominant profit engine. That low share in a big category makes Footwear a question mark in the BCG Matrix.
Activewear
Activewear is a Question Mark for FIGS because it moves the Company beyond medical uniforms into a crowded market. FIGS generated about $525 million in 2024 net revenues, but activewear’s share is still unclear, so the category’s upside is real and the payoff is not proven yet.
Loungewear
Loungewear broadens FIGS, Inc. beyond scrubs and gives the brand lifestyle crossover appeal with healthcare workers. It can lift average order value, but FIGS, Inc. does not disclose loungewear revenue separately, so its scale is hard to measure. Because it lacks the repeat purchase cadence of core scrubs, loungewear has upside, but also more demand risk.
Outerwear
Outerwear is a Question Mark for FIGS, Inc.: jackets and vests fit healthcare work, but the category is still split across many brands. FIGS has strong brand fit and can tap its active customer base, yet category leadership is not secure. Growth is there, but share still needs proof.
- Good use case for clinicians
- Fragmented market, weak leader
- Brand fit helps, share uncertain
Sports bras
Sports bras push FIGS deeper into women’s athleisure, a huge market where Nike, Lululemon, and Under Armour already set a high bar. That makes the line a classic question mark: the upside is real, but FIGS still has low share and must win on fit, comfort, and brand trust.
- Big market
- Intense rivalry
- Low share, high upside
FIGS’ Big Bets: Strong Fit, Unproven Market Share
FIGS, Inc.'s question marks are Footwear, Activewear, Loungewear, Outerwear, and Sports bras: each fits the brand, but each faces large, crowded markets where FIGS, Inc. has not shown clear share leadership. With about $525 million in 2024 net revenue, FIGS, Inc. has scale, but these lines still need proof of demand, margin, and repeat buy strength.
| Category | BCG view | Why |
|---|---|---|
| Footwear | Question Mark | Big market, low share |
| Activewear | Question Mark | Crowded, unproven scale |
| Outerwear | Question Mark | Fit is strong, leader unclear |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.